Virus and Autoantigen-Specific CD4+ T Cells Are Key Effectors in a SCID Mouse Model of EBV-Associated Post-Transplant Lymphoproliferative Disorders

PLoS Pathogens - United States
doi 10.1371/journal.ppat.1004068
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Evaluation of Histogenesis of B-Lymphocytes in Pediatric EBV-related Post-Transplant Lymphoproliferative Disorders

Bone Marrow Transplantation
TransplantationHematology
2003English

Management of Post-Transplant Lymphoproliferative Disorders

British Journal of Haematology
Hematology
2018English

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders

Frontiers in Oncology
Cancer ResearchOncology
2019English

Rethinking the Elusive Boundaries of EBV-associated T/NK-cell Lymphoproliferative Disorders

Haematologica
Hematology
2019English

Single-Center Analysis of Post-Transplant Lymphoproliferative Disorder (Ptld) Outcomes With Epstein Barr Virus (Ebv) Assessments

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Mutational Landscape of B-Cell Post-Transplant Lymphoproliferative Disorders

British Journal of Haematology
Hematology
2017English

Additional Considerations Related to the Elusive Boundaries of EBV-associated T/NK-cell Lymphoproliferative Disorders

Haematologica
Hematology
2019English

Automated Quantification of Epstein-Barr Virus in Whole Blood for Post-Transplant Lymphoproliferative Disorders Monitoring

Virology Journal
VirologyInfectious Diseases
2020English

Cancer Risk Following Post-Transplant Lymphoproliferative Disorders in Solid Organ Transplant Recipients

British Journal of Haematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy